Works matching AU Krex, Dietmar


Results: 57
    1

    Genome-wide association study of intracranial aneurysm identifies three new risk loci.

    Published in:
    Nature Genetics, 2010, v. 42, n. 5, p. 420, doi. 10.1038/ng.563
    By:
    • Yasuno, Katsuhito;
    • Bilguvar, Kaya;
    • Bijlenga, Philippe;
    • Siew-Kee Low;
    • Krischek, Boris;
    • Auburger, Georg;
    • Simon, Matthias;
    • Krex, Dietmar;
    • Arlier, Zulfikar;
    • Nayak, Nikhil;
    • Ruigrok, Ynte M.;
    • Niemelä, Mika;
    • Tajima, Atsushi;
    • von und zu Fraunberg, Mikael;
    • Dóczi, Tamás;
    • Wirjatijasa, Florentina;
    • Hata, Akira;
    • Blasco, Jordi;
    • Oszvald, Agi;
    • Kasuya, Hidetoshi
    Publication type:
    Article
    2
    3
    4
    5

    Clinical confocal laser endomicroscopy for imaging of autofluorescence signals of human brain tumors and non-tumor brain.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2025, v. 151, n. 1, p. 1, doi. 10.1007/s00432-024-06052-2
    By:
    • Reichenbach, Marlen;
    • Richter, Sven;
    • Galli, Roberta;
    • Meinhardt, Matthias;
    • Kirsche, Katrin;
    • Temme, Achim;
    • Emmanouilidis, Dimitrios;
    • Polanski, Witold;
    • Prilop, Insa;
    • Krex, Dietmar;
    • Sobottka, Stephan B.;
    • Juratli, Tareq A.;
    • Eyüpoglu, Ilker Y.;
    • Uckermann, Ortrud
    Publication type:
    Article
    6
    7
    8
    9

    Novel <i>CIC</i> Point Mutations and an Exon-Spanning, Homozygous Deletion Identified in Oligodendroglial Tumors by a Comprehensive Genomic Approach Including Transcriptome Sequencing.

    Published in:
    PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0076623
    By:
    • Eisenreich, Sophie;
    • Abou-El-Ardat, Khalil;
    • Szafranski, Karol;
    • Campos Valenzuela, Jaime A.;
    • Rump, Andreas;
    • Nigro, Janice M.;
    • Bjerkvig, Rolf;
    • Gerlach, Eva-Maria;
    • Hackmann, Karl;
    • Schröck, Evelin;
    • Krex, Dietmar;
    • Kaderali, Lars;
    • Schackert, Gabriele;
    • Platzer, Matthias;
    • Klink, Barbara
    Publication type:
    Article
    10
    11

    Chemotherapy for intracranial ependymoma in adults.

    Published in:
    2016
    By:
    • Gramatzki, Dorothee;
    • Roth, Patrick;
    • Felsberg, Jörg;
    • Hofer, Silvia;
    • Rushing, Elisabeth J.;
    • Hentschel, Bettina;
    • Westphal, Manfred;
    • Krex, Dietmar;
    • Simon, Matthias;
    • Schnell, Oliver;
    • Wick, Wolfgang;
    • Reifenberger, Guido;
    • Weller, Michael
    Publication type:
    journal article
    12
    13
    14
    15
    16
    17
    18

    Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.

    Published in:
    2023
    By:
    • Zeyen, Thomas;
    • Paech, Daniel;
    • Weller, Johannes;
    • Schäfer, Niklas;
    • Tzaridis, Theophilos;
    • Duffy, Cathrina;
    • Nitsch, Louisa;
    • Schneider, Matthias;
    • Potthoff, Anna-Laura;
    • Steinbach, Joachim Peter;
    • Hau, Peter;
    • Schlegel, Uwe;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Grauer, Oliver;
    • Goldbrunner, Roland;
    • Zeiner, Pia Susan;
    • Tabatabai, Ghazaleh;
    • Galldiks, Norbert;
    • Stummer, Walter
    Publication type:
    Correction Notice
    19

    Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.

    Published in:
    Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 607, doi. 10.1007/s11060-023-04444-x
    By:
    • Zeyen, Thomas;
    • Paech, Daniel;
    • Weller, Johannes;
    • Schäfer, Niklas;
    • Tzaridis, Theophilos;
    • Duffy, Cathrina;
    • Nitsch, Louisa;
    • Schneider, Matthias;
    • Potthoff, Anna-Laura;
    • Steinbach, Joachim Peter;
    • Hau, Peter;
    • Schlegel, Uwe;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Grauer, Oliver;
    • Goldbrunner, Roland;
    • Zeiner, Pia Susan;
    • Tabatabai, Ghazaleh;
    • Galldiks, Norbert;
    • Stummer, Walter
    Publication type:
    Article
    20

    Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up.

    Published in:
    Journal of Neuro-Oncology, 2023, v. 164, n. 2, p. 353, doi. 10.1007/s11060-023-04419-y
    By:
    • Pertz, Milena;
    • Schlömer, Sabine;
    • Seidel, Clemens;
    • Hentschel, Bettina;
    • Löffler, Markus;
    • Schackert, Gabriele;
    • Krex, Dietmar;
    • Juratli, Tareq;
    • Tonn, Joerg Christian;
    • Schnell, Oliver;
    • Vatter, Hartmut;
    • Simon, Matthias;
    • Westphal, Manfred;
    • Martens, Tobias;
    • Sabel, Michael;
    • Bendszus, Martin;
    • Dörner, Nils;
    • Wick, Antje;
    • Fliessbach, Klaus;
    • Hoppe, Christian
    Publication type:
    Article
    21

    Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS.

    Published in:
    Journal of Neuro-Oncology, 2022, v. 159, n. 1, p. 95, doi. 10.1007/s11060-022-04046-z
    By:
    • Weller, Johannes;
    • Schäfer, Niklas;
    • Schaub, Christina;
    • Potthoff, Anna-Laura;
    • Steinbach, Joachim P.;
    • Schlegel, Uwe;
    • Sabel, Michael;
    • Hau, Peter;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Goldbrunner, Roland;
    • Pietsch, Torsten;
    • Tzaridis, Theophilos;
    • Zeyen, Thomas;
    • Borger, Valeri;
    • Güresir, Erdem;
    • Vatter, Hartmut;
    • Herrlinger, Ulrich;
    • Schneider, Matthias
    Publication type:
    Article
    22

    Mid-term treatment-related cognitive sequelae in glioma patients.

    Published in:
    Journal of Neuro-Oncology, 2022, v. 159, n. 1, p. 65, doi. 10.1007/s11060-022-04044-1
    By:
    • Schlömer, Sabine;
    • Felsberg, Jörg;
    • Pertz, Milena;
    • Hentschel, Bettina;
    • Löffler, Markus;
    • Schackert, Gabriele;
    • Krex, Dietmar;
    • Juratli, Tareq;
    • Tonn, Joerg Christian;
    • Schnell, Oliver;
    • Vatter, Hartmut;
    • Simon, Matthias;
    • Westphal, Manfred;
    • Martens, Tobias;
    • Sabel, Michael;
    • Bendszus, Martin;
    • Dörner, Nils;
    • Fliessbach, Klaus;
    • Hoppe, Christian;
    • Reifenberger, Guido
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide.

    Published in:
    Journal of Neuro-Oncology, 2010, v. 96, n. 3, p. 393, doi. 10.1007/s11060-009-9976-3
    By:
    • Dresemann, Gregor;
    • Weller, Michael;
    • Rosenthal, Mark A.;
    • Wedding, Ulrich;
    • Wagner, Wolfgang;
    • Engel, Erik;
    • Heinrich, Bernhard;
    • Mayer-Steinacker, Regine;
    • Karup-Hansen, Anders;
    • Fluge, Øystein;
    • Nowak, Anna;
    • Mehdorn, Maximilian;
    • Schleyer, Eberhard;
    • Krex, Dietmar;
    • Olver, Ian N.;
    • Steinbach, Joachim P.;
    • Hosius, Christian;
    • Sieder, Christian;
    • Sorenson, Greg;
    • Parker, Richard
    Publication type:
    Article
    30
    31
    32

    MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA‐09 trial.

    Published in:
    International Journal of Cancer, 2021, v. 148, n. 7, p. 1695, doi. 10.1002/ijc.33363
    By:
    • Tzaridis, Theophilos;
    • Schäfer, Niklas;
    • Weller, Johannes;
    • Steinbach, Joachim‐Peter;
    • Schlegel, Uwe;
    • Seidel, Sabine;
    • Sabel, Michael;
    • Hau, Peter;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Goldbrunner, Roland;
    • Tonn, Jörg‐Christian;
    • Grauer, Oliver;
    • Kebir, Sied;
    • Schneider, Matthias;
    • Schaub, Christina;
    • Vatter, Hartmut;
    • Coch, Christoph;
    • Glas, Martin;
    • Fimmers, Rolf
    Publication type:
    Article
    33

    Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.

    Published in:
    EMBO Molecular Medicine, 2016, v. 8, n. 1, p. 39, doi. 10.15252/emmm.201505505
    By:
    • Scholz, Alexander;
    • Harter, Patrick N;
    • Cremer, Sebastian;
    • Yalcin, Burak H;
    • Gurnik, Stefanie;
    • Yamaji, Maiko;
    • Di Tacchio, Mariangela;
    • Sommer, Kathleen;
    • Baumgarten, Peter;
    • Bähr, Oliver;
    • Steinbach, Joachim P;
    • Trojan, Jörg;
    • Glas, Martin;
    • Herrlinger, Ulrich;
    • Krex, Dietmar;
    • Meinhardt, Matthias;
    • Weyerbrock, Astrid;
    • Timmer, Marco;
    • Goldbrunner, Roland;
    • Deckert, Martina
    Publication type:
    Article
    34
    35
    36

    INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas.

    Published in:
    Neurological Research & Practice, 2023, v. 5, n. 1, p. 1, doi. 10.1186/s42466-023-00282-4
    By:
    • Grassl, Niklas;
    • Sahm, Katharina;
    • Süße, Heike;
    • Poschke, Isabel;
    • Bunse, Lukas;
    • Bunse, Theresa;
    • Boschert, Tamara;
    • Mildenberger, Iris;
    • Rupp, Anne-Kathleen;
    • Ewinger, Max Philipp;
    • Lanz, Lisa-Marie;
    • Denk, Monika;
    • Tabatabai, Ghazaleh;
    • Ronellenfitsch, Michael W.;
    • Herrlinger, Ulrich;
    • Glas, Martin;
    • Krex, Dietmar;
    • Vajkoczy, Peter;
    • Wick, Antje;
    • Harting, Inga
    Publication type:
    Article
    37
    38

    Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial.

    Published in:
    Trials, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13063-021-05977-0
    By:
    • Zeyen, Thomas;
    • Potthoff, Anna-Laura;
    • Nemeth, Robert;
    • Heiland, Dieter H.;
    • Burger, Michael C.;
    • Steinbach, Joachim P.;
    • Hau, Peter;
    • Tabatabai, Ghazaleh;
    • Glas, Martin;
    • Schlegel, Uwe;
    • Grauer, Oliver;
    • Krex, Dietmar;
    • Schnell, Oliver;
    • Goldbrunner, Roland;
    • Sabel, Michael;
    • Thon, Niklas;
    • Delev, Daniel;
    • Clusmann, Hans;
    • Seidel, Clemens;
    • Güresir, Erdem
    Publication type:
    Article
    39

    Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.

    Published in:
    2022
    By:
    • Zeyen, Thomas;
    • Potthoff, Anna-Laura;
    • Nemeth, Robert;
    • Heiland, Dieter H.;
    • Burger, Michael C.;
    • Steinbach, Joachim P.;
    • Hau, Peter;
    • Tabatabai, Ghazaleh;
    • Glas, Martin;
    • Schlegel, Uwe;
    • Grauer, Oliver;
    • Krex, Dietmar;
    • Schnell, Oliver;
    • Goldbrunner, Roland;
    • Sabel, Michael;
    • Thon, Niklas;
    • Delev, Daniel;
    • Clusmann, Hans;
    • Seidel, Clemens;
    • Güresir, Erdem
    Publication type:
    journal article
    40
    41
    42
    43
    44

    The Stem Cell Marker Prominin-1/CD133 on Membrane Particles in Human Cerebrospinal Fluid Offers Novel Approaches for Studying Central Nervous System Disease.

    Published in:
    Stem Cells, 2008, v. 26, n. 3, p. 698, doi. 10.1634/stemcells.2007-0639
    By:
    • Huttner, Hagen B.;
    • Janich, Peggy;
    • Köhrmann, Martin;
    • Jászai, József;
    • Siebzehnrubl, Florian;
    • Blümcke, Ingmar;
    • Suttorp, Meinolf;
    • Gahr, Manfred;
    • Kuhnt, Daniela;
    • Nimsky, Christopher;
    • Krex, Dietmar;
    • Schackert, Gabriele;
    • Löwenbrück, Kai;
    • Reichmann, Heinz;
    • Jüttler, Eric;
    • Hacke, Werner;
    • Schellinger, Peter D.;
    • Schwab, Stefan;
    • Wilsch-Bräuninger, Michaela;
    • Marzesco, Anne-Marie
    Publication type:
    Article
    45
    46

    Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma.

    Published in:
    Acta Neuropathologica, 2024, v. 147, n. 1, p. 1, doi. 10.1007/s00401-023-02662-1
    By:
    • Weller, Michael;
    • Felsberg, Jörg;
    • Hentschel, Bettina;
    • Gramatzki, Dorothee;
    • Kubon, Nadezhda;
    • Wolter, Marietta;
    • Reusche, Matthias;
    • Roth, Patrick;
    • Krex, Dietmar;
    • Herrlinger, Ulrich;
    • Westphal, Manfred;
    • Tonn, Joerg C.;
    • Regli, Luca;
    • Maurage, Claude-Alain;
    • von Deimling, Andreas;
    • Pietsch, Torsten;
    • Le Rhun, Emilie;
    • Reifenberger, Guido
    Publication type:
    Article
    47

    Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide.

    Published in:
    Neuro-Oncology, 2025, v. 27, n. 2, p. 557, doi. 10.1093/neuonc/noae205
    By:
    • Zeyen, Thomas;
    • Böhm, Laura;
    • Paech, Daniel;
    • Schäfer, Niklas;
    • Tzaridis, Theophilos;
    • Duffy, Cathrina;
    • Nitsch, Louisa;
    • Schneider, Matthias;
    • Potthoff, Anna-Laura;
    • Schneider-Rothhaar, Javen Lennard;
    • Steinbach, Joachim Peter;
    • Hau, Peter;
    • Kowalski, Thomas;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Grauer, Oliver;
    • Goldbrunner, Roland;
    • Zeiner, Pia Susan;
    • Tabatabai, Ghazaleh;
    • Galldiks, Norbert
    Publication type:
    Article
    48
    49
    50

    Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 7, p. 975, doi. 10.1093/neuonc/nox204
    By:
    • Schäfer, Niklas;
    • Proescholdt, Martin;
    • Steinbach, Joachim P.;
    • Weyerbrock, Astrid;
    • Hau, Peter;
    • Grauer, Oliver;
    • Goldbrunner, Roland;
    • Friedrich, Franziska;
    • Rohde, Veit;
    • Ringel, Florian;
    • Schlegel, Uwe;
    • Sabel, Michael;
    • Ronellenfitsch, Michael W.;
    • Uhl, Martin;
    • Grau, Stefan;
    • Hänel, Mathias;
    • Schnell, Oliver;
    • Krex, Dietmar;
    • Vajkoczy, Peter;
    • Tabatabai, Ghazaleh
    Publication type:
    Article